Healthcare provider profile · identity verified

Benjamin Bukey

Family Practice · QUINCY, IL · NPI 1598294696

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	394	110
Lisinopril	Lisinopril	326	83
Amlodipine Besylate	Amlodipine Besylate	246	56
Losartan Potassium	Losartan Potassium	219	65
Metformin Hcl	Metformin Hcl	207	58
Levothyroxine Sodium	Levothyroxine Sodium	202	48
Pantoprazole Sodium	Pantoprazole Sodium	188	45
Omeprazole	Omeprazole	187	42
Albuterol Sulfate Hfa	Albuterol Sulfate	176	53
Hydrochlorothiazide	Hydrochlorothiazide	169	41
Gabapentin	Gabapentin	160	34
Metoprolol Tartrate	Metoprolol Tartrate	144	30
Jardiance	Empagliflozin	139	23
Tamsulosin Hcl	Tamsulosin Hcl	139	43
Tramadol Hcl	Tramadol Hcl	131	31
Metoprolol Succinate	Metoprolol Succinate	130	33
Simvastatin	Simvastatin	130	37
Ozempic	Semaglutide	122	23
Carvedilol	Carvedilol	114	27
Rosuvastatin Calcium	Rosuvastatin Calcium	104	31
Sertraline Hcl	Sertraline Hcl	104	24
Metformin Hcl Er	Metformin Hcl	103	27
Furosemide	Furosemide	102	27
Potassium Chloride	Potassium Chloride	90	22
Fluticasone Propionate	Fluticasone Propionate	87	26
Baclofen	Baclofen	85	13
Trulicity	Dulaglutide	81	13
Duloxetine Hcl	Duloxetine Hcl	77	18
Glipizide	Glipizide	74	15
Trazodone Hcl	Trazodone Hcl	74	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	26
Montelukast Sodium	Montelukast Sodium	69	21
Eliquis	Apixaban	66	14
Xarelto	Rivaroxaban	66	suppressed
Alendronate Sodium	Alendronate Sodium	63	16
Fluoxetine Hcl	Fluoxetine Hcl	62	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	17
Famotidine	Famotidine	60	12
Glipizide Er	Glipizide	60	12
Pravastatin Sodium	Pravastatin Sodium	60	15
Ropinirole Hcl	Ropinirole Hcl	60	11
Meloxicam	Meloxicam	58	17
Allopurinol	Allopurinol	50	17
Clopidogrel	Clopidogrel Bisulfate	48	suppressed
Pregabalin	Pregabalin	48	12
Ezetimibe	Ezetimibe	47	suppressed
Warfarin Sodium	Warfarin Sodium	47	13
Alprazolam	Alprazolam	46	15
Januvia	Sitagliptin Phosphate	43	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	41	11
Mirtazapine	Mirtazapine	41	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	40	suppressed
Lovastatin	Lovastatin	40	suppressed
Mounjaro	Tirzepatide	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	suppressed
Topiramate	Topiramate	40	suppressed
Chlorthalidone	Chlorthalidone	39	suppressed
Prednisone	Prednisone	39	22
Celecoxib	Celecoxib	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Finasteride	Finasteride	34	15
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Meclizine Hcl	Meclizine Hcl	30	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Naproxen	Naproxen	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Glimepiride	Glimepiride	23	suppressed
Atenolol	Atenolol	22	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Cephalexin	Cephalexin	20	19
Farxiga	Dapagliflozin Propanediol	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Nystatin	Nystatin	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Torsemide	Torsemide	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Bupropion Hcl	Bupropion Hcl	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Colchicine	Colchicine	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Valsartan	Valsartan	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Theophylline Er	Theophylline Anhydrous	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error